Alternatives to Delineate

PicnicAI turns patient health records into clinical research data and real-world evidence.

Open-source Python framework that assembles causal and mechanistic models from literature and biological databases.

Frekils runs end-to-end real-world evidence studies on your clinical data, with AI writing the statistical code and your patient records never leaving your

Owkin's K Pro is an autonomous AI scientist agent for biopharma R&D, turning multimodal patient data into drug discovery and clinical trial

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Oncology real-world evidence platform combining high-fidelity patient data with AI-assisted cancer research insights.

All-in-human AI foundation models for precision neurology — vBx-1.0 predicts brain activity and therapy response from a blood draw.

Quibim turns MRI, CT and PET scans into regulatory-cleared quantitative imaging biomarkers for prostate, brain, liver, breast and lung.

Recursion runs AI drug discovery as a lab-in-the-loop engine — automated cellular imaging at scale feeding generative chemistry and a clinical pipeline.

AI patient identification for clinical trials: HealthKey scans your EHR daily and emails your team trial-eligible patients.

Cellbyte is the AI workspace where pharma Pricing & Market Access teams get source-linked HTA and pricing answers in minutes.

Project-based AI biopharma team that delivers decision-grade research, analysis, and computational design in 3–5 days.

NExTNet pairs an evidence-backed life sciences Copilot with Explorer knowledge maps over a deterministic biomedical ontology.

AI-native pharma company using autonomous agents to find new uses for existing drugs and predict patient drug response

Haplotype Labs builds SaaS and community tooling for population genetics, aiming to cut sequencing costs 50–90% and speed polygenic risk modeling.

Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

Recursion OS pairs automated wet labs with AI models for AI drug discovery at up to 2 million weekly experiments.

Evotec is a life-science partner running AI-assisted drug discovery and Just–Evotec Biologics manufacturing.

Silico is Goodfire's interpretability agent for understanding and debugging the internals of your AI models.

Nimbus Therapeutics designs highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Iktos pairs generative AI with robotic lab automation to compress small-molecule drug discovery.

Renamed: Deep 6 AI was acquired by Tempus AI in March 2025 and its trial matching folded into Tempus.

Physics-based molecular simulation with AI for drug discovery and materials design.

Benchling unifies ELN, LIMS, and AI agents for biotech R&D in one cloud platform.

FDA-cleared AI for cancer pathology: prostate, breast, GI and pan-cancer detection on H&E slides, plus Virchow foundation models for research.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches

Causal AI drug discovery pairing 20+ petabytes of cellular data with human genetics to find true disease targets

Cradle is an AI protein engineering platform that designs optimised variant plates from your own wet-lab results and feeds each round back into the models.